Alta Care Group has been awarded a $123,151 grant from the OneOhio Recovery Foundation to expand the YouthMOVE program.

These require initial proof-of-concept demonstration that treatment administration increases alpha-1 antitrypsin (AAT) levels and/or anti-neutrophil elastase inhibitory capacity (ANEC) in the lung.